ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $329,000 | -34.2% | 15,075 | -9.9% | 0.01% | -36.4% |
| Q3 2021 | $500,000 | -54.8% | 16,731 | -32.9% | 0.01% | -54.2% |
| Q2 2021 | $1,105,000 | +3.6% | 24,948 | +3.7% | 0.02% | +4.3% |
| Q1 2021 | $1,067,000 | +69.1% | 24,054 | +109.2% | 0.02% | +91.7% |
| Q4 2020 | $631,000 | +37.2% | 11,500 | -42.9% | 0.01% | 0.0% |
| Q3 2020 | $460,000 | -8.5% | 20,127 | -16.2% | 0.01% | -14.3% |
| Q2 2020 | $503,000 | +49.3% | 24,024 | -0.6% | 0.01% | +7.7% |
| Q1 2020 | $337,000 | -25.9% | 24,171 | +20.9% | 0.01% | +85.7% |
| Q4 2019 | $455,000 | +95.3% | 20,000 | 0.0% | 0.01% | +40.0% |
| Q3 2019 | $233,000 | -8.6% | 20,000 | +17.6% | 0.01% | -28.6% |
| Q2 2019 | $255,000 | +16.4% | 17,000 | +36.0% | 0.01% | +40.0% |
| Q1 2019 | $219,000 | +5.8% | 12,500 | -10.7% | 0.01% | -44.4% |
| Q4 2018 | $207,000 | – | 14,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |